MedTrace Logo

The Evolution and Prognosis of Moyamoya Disease

NCT05619068 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-12-21

No results posted yet for this study

Summary

To investigate the evolution of imaging appearances and cognitive function of Moyamoya disease (MMD) and to establish a prognosis evaluation system based on imaging biomarkers in MMD. The study may be helpful to optimize and improve the diagnosis and pretreatment assessment of MMD, and provide an important theoretical supplement to the existing guidelines for the management of MMD.

Conditions

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Lou Xin, MD, PhD · Chinese PLA General Hospital

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05619068 on ClinicalTrials.gov